1 t rabbits were each injected with 5 units of
Botox.
2 79% received Botox or bag dilation: 52% had
Botox,
59% underwent dilation, and 36% had both.
3 chalasia, 21 with pneumatic dilation, 1 with
BOTOX,
6 with balloon and BOTOX, and 2 with transthoraci
4 antly more likely to respond to any therapy (
BoTox [
71%], pneumatic dilation [91%], or Heller myotomy
5 eral drug administration approved the use of
Botox (
Allergan, Irvine, CA) for glabellar furrows.
6 le agent in cosmetic applications (including
Botox and Dysport).
7 n, 23 had been treated with botulinum toxin (
Botox),
and 4 had undergone prior myotomy.
8 c dilation, 1 with BOTOX, 6 with balloon and
BOTOX,
and 2 with transthoracic cardiomyotomy.
9 s atrophy after intramuscular injection with
Botox,
extraocular muscles (EOMs) do not.
10 patients required surgery for anal fissure (
Botox +/-
fissurectomy 8; LIS 6).
11 were receiving preparations of neurotoxin A (
BOTOX)
for the treatment of spastic disorders.
12 Botox has recently been shown to be an effective interme
13 ys to maximize the clinical effectiveness of
Botox in patients with strabismus.
14 Botox-
induced EOM paralysis resulted in a significant sh
15 In this study, the effect of
Botox-
induced muscle paralysis on myofiber remodeling in
16 Of these, 154 had undergone either
Botox injection and/or pneumatic dilation preoperatively
17 myonuclei was significantly increased after
Botox injection in EOMs.
18 protein synthesis becomes upregulated after
Botox injection, and this, in turn, may help explain the
19 nimal effects on myofiber size in EOMs after
Botox injection.
20 Pneumatic dilatation and botulinum toxin (
BOTOX)
injection of the lower esophageal sphincter large
21 Newer therapies, including
Botox injections and new or broadened indications for ex
22 programs for treating dysfunctional voiding,
Botox injections for overactive bladder and an adult ant
23 nd the rate of song recovery after syringeal
Botox injections were correlated with the number of new
24 Six patients had prior dilations or
Botox injections.
25 BOTOX is manufactured with the purified native 900-kDa t
26 Botulinum toxin A (
Botox)
is commonly used for strabismus treatment.
27 Understanding the effect of
Botox on satellite cell activation and myonuclear additi
28 referred for surgery (100 dilation only, 33
Botox only, 21 both).
29 Before myotomy, 79% received
Botox or bag dilation: 52% had Botox, 59% underwent dila
30 Intramuscular injection of
Botox resulted in a significant increase in both the num
31 cious even after failures of dilation and/or
Botox therapy.
32 In
Botox-
treated EOMs, an increased number of myofibers pos
33 ) was administered for various periods after
Botox treatment, followed by various BrdU-free periods.
34 y manipulating syringeal muscle control with
Botox,
which produces a transient partial paralysis.